Immuntherapeutische Verfahren, Verbindungen und Zusammensetzungen zur Behandlung oder Prävention von Zöliakie
EP4786006
5. August 2026
Anmelder: DBV Technologies 🇫🇷
Details
- Veröffentlichungs-Nr.
- EP4786006
- Anmeldetag
- 20. Dezember 2024
- Veröffentlichung
- 5. August 2026
- Rechtsraum
- EP
- IPC
- A61P37/08
Abstract
The present application relates to a method for increasing tolerance to gliadin in a subject, in particular in a subject suffering from celiac disease, comprising repeatedly administered a polypeptide construct comprising several epitopes from gliadin isoforms preferably by epicutaneous route. The present application also relates to the polypeptide construct per se and a skin patch containing the same.
Anmelder
- Firma
- DBV Technologies
- Land
- 🇫🇷 Frankreich